中国报告大厅网讯，今年以来，以港股创新药为代表的医药板块表现强劲。截至2024年5月21日收盘，中证香港创新药指数（931787.CSI）近一个月涨幅达13.28%，年内累计上涨33.23%。Wind数据显示，全市场220只医疗主题基金平均收益为12.06%，其中14只产品年内回报率突破30%，最高者达55.32%。这一现象折射出创新药赛道在政策支持、资本涌入和产业周期共振下，正成为医药投资的核心...
Source Link中国报告大厅网讯，今年以来，以港股创新药为代表的医药板块表现强劲。截至2024年5月21日收盘，中证香港创新药指数（931787.CSI）近一个月涨幅达13.28%，年内累计上涨33.23%。Wind数据显示，全市场220只医疗主题基金平均收益为12.06%，其中14只产品年内回报率突破30%，最高者达55.32%。这一现象折射出创新药赛道在政策支持、资本涌入和产业周期共振下，正成为医药投资的核心...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.